Form 8-K - Current report:
SEC Accession No. 0001104659-06-061441
Filing Date
2006-09-15
Accepted
2006-09-15 16:48:26
Documents
6
Period of Report
2006-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-19670_18k.htm 8-K 26296
2 EX-1 a06-19670_1ex1d1.htm EX-1.1 246834
3 EX-5 a06-19670_1ex5d1.htm EX-5.1 11414
4 EX-99 a06-19670_1ex99d1.htm EX-99.1 5881
5 GRAPHIC g196701kli001.jpg GRAPHIC 2445
6 GRAPHIC g196701kmi001.gif GRAPHIC 9714
  Complete submission text file 0001104659-06-061441.txt   308917
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 061093837
SIC: 2834 Pharmaceutical Preparations